Comprehensive Neuropsychiatric, Psychopharmacology, Mood Disorders, Substance Use, Withdrawal Syndromes, Treatment Strategies, Risk Assessment, Patient Compliance, Crisis Management, and Behavioral Interventions Guide Questions Complete and Verified with

Comprehensive Neuropsychiatric, Psychopharmacology, Mood Disorders, Substance Use, Withdrawal Syndromes, Treatment Strategies, Risk Assessment, Patient Compliance, Crisis Management, and Behavioral Interventions Guide Questions Complete and Verified with A+ Graded Rationales Latest Updated 2026 Schedule 1 What Schedule? -Heroin -LSD -Cannabis -Ectasy -Methaqualone -Peyote Schedule 2 What Schedule? -Hydrocodone -Cocaine -Methamphetamine -Methadone -Dilaudid -Demerol -Oxycontin -Fentanyl -Dexedrine -Adderall -Ritalin Schedule 3 What Schedule? -Codeine (90 mg per dosage) -Ketamine -Anabolic Steroids -Testosterone Schedule 4 What Schedule? -Xanax -Soma -Valium -Ativan -Ambien -Tramadol Schedule 5 What Schedule? -Lotmotil -Motofen -Lyrica -Parepectolin 1. Ventral Tegmental Area (VTA) 2. Nucleus Accumbens 3. Medial Forebrain Bundle 4. Prefrontal Cortex The parts and flow of the Reward Pathway Mild ___________ Substance Use Disorder: -2-3 symptoms Moderate ___________ Substance Use Disorder: -4-5 symptoms Severe ___________ Substance Use Disorder: -6+ symptoms Benzodiazepines and Opioids FDA added a black box warning for the concomitant use of this combination due to the result of profound sedation, respiratory depression, coma, and death. Benzodiazepines and Opioids • Reserve concomitant use for those patients whom treating options are inadequate • Limit dosages and durations to the minimum required • Follow patients for signs/symptoms of respiratory depression and sedation That you are aware of the-prescribing and that you have discussed the risks with the patient and rationale for the choice If you have to prescrib